Oppenheimer & CO Inc Ionis Pharmaceuticals Inc Transaction History

Oppenheimer & CO Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$31.71 - $43.0 $63,420 - $86,000	-2,000 Reduced 12.08%	14,560 $539,000
Q1 2022 May 12, 2022	SELL	$29.88 - $37.04 $53,724 - $66,597	-1,798 Reduced 9.79%	16,560 $613,000
Q4 2021 Feb 02, 2022	SELL	$25.61 - $35.1 $70,914 - $97,191	-2,769 Reduced 13.11%	18,358 $559,000
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $7,412 - $8,961	-221 Reduced 1.04%	21,127 $709,000
Q2 2021 Aug 03, 2021	BUY	$34.54 - $47.25 $737,359 - $1.01 Million	21,348 New	21,348 $852,000
Q2 2019 Aug 09, 2019	SELL	$62.09 - $86.14 $292,754 - $406,150	-4,715 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$52.92 - $81.17 $249,517 - $382,716	4,715 New	4,715 $383,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.